Cargando…
Lp(a): a New Pathway to Target?
PURPOSE OF REVIEW: Over the past decades, genetic and observational evidence has positioned lipoprotein(a) as novel important and independent risk factor for cardiovascular disease (ASCVD) and aortic valve stenosis. RECENT FINDINGS: As Lp(a) levels are determined genetically, lifestyle interventions...
Autores principales: | Nurmohamed, Nick S., Kraaijenhof, Jordan M., Stroes, Erik S. G. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer US
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9534805/ https://www.ncbi.nlm.nih.gov/pubmed/36066785 http://dx.doi.org/10.1007/s11883-022-01060-4 |
Ejemplares similares
-
PCSK9 Monoclonal Antibodies: New Developments and Their Relevance in a Nucleic Acid–Based Therapy Era
por: Gouni-Berthold, Ioanna, et al.
Publicado: (2022) -
Bempedoic Acid: for Whom and When
por: Ruscica, Massimiliano, et al.
Publicado: (2022) -
Inclisiran: How Widely and When Should We Use It?
por: Pirillo, Angela, et al.
Publicado: (2022) -
Different inflammatory pathways underlying cardiovascular risk in secondary prevention( )
por: Nurmohamed, Nick S, et al.
Publicado: (2022) -
Best Practices for Data Sharing in Phylogenetic Research
por: Cranston, Karen, et al.
Publicado: (2014)